Trump administration’s biotech oversight plan echoes Obama’s, but regulatory approach remains unknown

download

Editor’s note:ย Gregory Jaffe is the director of the project on biotechnology at theย Center for Science in the Public Interest

In 2017, agricultural biotechnology was not high on the U.S. Department of Agricultureโ€™s (USDA) policy agenda. Then, this month, the USDA released itsย report on Agriculture and Rural Prosperity, which highlights the value of biotechnology innovation in U.S. agriculture and recommends streamlining biotechnology regulations. While the reportโ€™s recommendations donโ€™t seem to differ from positions taken by the Obama administration, it will be important to watch how the Trump administration implements them in the coming months.

It calls for the White Houseโ€™s Office of Science and Technology Policy (OSTP) to coordinate and improve science-based regulatory approaches among the relevant agencies. (This is all well and good, but the fact is that OSTP has been decimated under the Trump administration and only has a shoestring staff.)

The Trump administration should strive for appropriate risk-based oversight, and should not rush, in a deregulatory zeal, to eliminate regulations that are needed to ensure safety and consumer confidence, both domestically and internationally.

How (and how quickly) the reportโ€™s recommendations are implemented will tell us how important agricultural biotechnology will be during the Trump administration.

Read full, original post:ย Biotechnology and Biosafety Policy Under the Trump Administration: The Devil Will Be in the Details

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-05-26 at 10.15
Viewpoint: Double standardโ€”Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
โ€˜You donโ€™t understand Tolkienโ€™: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpointโ€”N.A.D.+: Why Gwenyth Paltrowโ€™s heralded anti-aging supplement doesnโ€™t work
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
Screenshot-2026-06-04-at-12.05.08-PM
Cases of brain inflammation surge as U.S. measles pandemic approaches 2000
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
ChatGPT Image May 26, 2026, 08_42_17 AM (1)
Viewpoint: Greenpeace and poison: How environmental advocacy groups rely on compliant (and often ignorant) journalists to spread disinformation and spark litigation
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpointโ€”โ€œMiracle moleculeโ€ debunked: Why acemannan supplements donโ€™t work
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile โ€˜thought experimentโ€™
ChatGPT Image May 26, 2026, 08_21_36 AM
Limiting gender affirming interventions: Trump administration targets Texas even though it already bans youth access

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.